Supply agreement for the drug empagliflozin

This tender, issued by the Servicio de Salud Arica Hosp Dr Juan Noe Crevani, concerns a supply agreement for the pharmaceutical product Empagliflozin. Specifically, the requirement is for Empagliflozin 25 mg film-coated tablets, with a total quantity of 460,000 units. This falls under the category of industrial production and manufacturing services, specifically within the chemical products and pharmaceutical production sectors.

Bidders are required to submit all annexes with the legal representative's signature, as stipulated in Administrative Bases Article No. 13 regarding proposal submission. Additionally, prospective suppliers must provide updated company incorporation documents detailing the legal representatives, a certificate of powers of attorney (valid for 3 months from issuance), and a copy of the bid security bond. If the bid security bond is physical, it must be sent to 18 de Septiembre Nº 1000, Arica, addressed to Ms. Teresa Romero, Supply Officer. For electronic bid security bonds, they should be sent to the following email addresses: teresa.romero@hjnc.cl, rodrigo.soriano@hjnc.cl, roberto.gutierrez@hjnc.cl, daniela.fernandez@hjnc.cl, and herman.geraldo.1@hjnc.cl. The funding for this supply agreement will be sourced from the hospital's budget. The tender is relevant to the Arica y Parinacota Region.

This is a services contract in the health and medical services, trade and industry and legal services sectors, with a focus on Hospitals. Located in Chile, Latin America, this opportunity is open to firms and consortiums.

Published through Chile Mercado Publico, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for services in the health and medical services sector. Service contracts are typically evaluated on both technical quality and price, and may require bidders to demonstrate relevant experience and qualified personnel. This contract has already been awarded. The information is published for transparency and market intelligence purposes.